Real-World Patients With Obstructive Hypertrophic Cardiomyopathy Treated With Mavacamten: A US Single Center Experience

被引：0
|
作者：
Reza, Nosheen
Dubey, Anand
Carattini, Thomas
Maya, Juan
Ferri, Mauricio
Botros, Afraim
Marzolf, Amy
Hornsby, Nicole
de Feria, Alejandro
Owens, Anjali T.
机构：
来源：
CIRCULATION | 2023年 / 148卷
关键词：
Hypertrophic cardiomyopathy; Myosin; Cardiovascular therapeutics; Precision medicine; Echocardiography;
D O I：
10.1161/circ.148.suppl_1.13955
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A13955
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Cardiovascular Toxicity in Cancer Patients Treated with Tyrosine Kinase Inhibitors: A Real-World Single-Center Experience
    Novo, Giuseppina
    Di Lisi, Daniela
    Bronte, Enrico
    Macaione, Francesca
    Accurso, Vincenzo
    Badalamenti, Giuseppe
    Rinaldi, Gaetana
    Siragusa, Sergio
    Novo, Salvatore
    Russo, Antonio
    ONCOLOGY, 2020, 98 (07) : 445 - 451
  • [42] Septal microsphere embolization in hypertrophic obstructive cardiomyopathy: A quindecennial single-center experience
    Janosi, R. A.
    Luedike, P.
    Rassaf, T.
    Papathanasiou, M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 378 - 378
  • [43] Nonsurgical versus surgical treatment for hypertrophic obstructive cardiomyopathy: a single-center experience
    van der Lee, C
    Pedone, C
    Geleijnse, M
    CIRCULATION, 2004, 110 (17) : 678 - 679
  • [44] COST-EFFECTIVENESS OF MAVACAMTEN FOR THE TREATMENT OF PATIENTS WITH SYMPTOMATIC OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN THE NETHERLANDS
    Buisman, L.
    Treur, M.
    Verkaik, M.
    Van De Wetering, G.
    Pronk, L. M.
    Pompen, M.
    Hurst, M.
    VALUE IN HEALTH, 2023, 26 (12) : S110 - S110
  • [45] The Effect of Mavacamten Treatment on Hemolysis Biomarkers in Patients With Obstructive Hypertrophic Cardiomyopathy in the EXPLORERHCM Study
    Wang, Zhaoqing
    Anderson, Warren
    Sehnert, Amy J.
    He, Aiqing
    Kurio, Gregory
    Olivotto, Iacopo
    Schafer, Peter
    CIRCULATION, 2023, 148
  • [46] Early Observations on Effects of Mavacamten on Left Atrial Function in Obstructive Hypertrophic Cardiomyopathy Patients
    Wessly, Priscilla
    Lazzara, Gina E.
    Buergler, John M.
    Nagueh, Sherif F.
    JACC-CARDIOVASCULAR IMAGING, 2023, 16 (12) : 1633 - 1634
  • [47] Hypertrophic Cardiomyopathy in "Real-World" Community Cardiology Practice
    Rowin, Ethan J.
    Maron, Martin S.
    Bhatt, Viraj
    Gillam, Linda
    Maron, Barry J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 125 (09): : 1398 - 1403
  • [48] Genotype Analysis of LVOT Gradient Measurements in Patients Receiving Mavacamten for Obstructive Hypertrophic Cardiomyopathy?
    Chandrasekhar, S. A.
    Cornelio, C. K.
    Miranda, A. C.
    Wu, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2024, 43 (04): : S504 - S504
  • [49] An italian real-world analysis of obstructive hypertrophic cardiomyopathy through a large administrative healthcare database
    Maggioni, A. P.
    Ronconi, G.
    Dondi, L.
    Dondi, L.
    Calabria, S.
    Dell Anno, I.
    Piccinni, C.
    Pedrini, A.
    Esposito, I.
    Addesi, A.
    Martini, N.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [50] Long-Term Efficacy and Safety of Mavacamten in Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
    Day, Sharlene M.
    Udelson, James E.
    Bonow, Robert O.
    JAMA CARDIOLOGY, 2023, 8 (10) : 978 - 978
12345